Overexpression of mutant p53 and c-erbB-2 proteins and breast tumour take in mice.

por Mehta, R. R., Graves, J. M., Warso, M. A., Das Gupta, T. K.
Publicado 1995

A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours

por Warso, M A, Richards, J M, Mehta, D, Christov, K, Schaeffer, C, Rae Bressler, L, Yamada, T, Majumdar, D, Kennedy, S A, Beattie, C W, Das Gupta, T K
Publicado 2013